$ALDX Aldeyra Therapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Aldeyra Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Aldeyra Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Aldeyra Therapeutics, Inc. for free.

CIK Number: 0001341235
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ALDX
Company Address: 131 HARTWELL AVENUE SUITE 320 LEXINGTON 02421
Phone number: 781-761-4904
Former name: Neuron Systems Inc, date of change: 2005-10-12
Former name: Aldexa Therapeutics, Inc., date of change: 2013-01-02

Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Market Capitalization: $30.29M
Prev close: $5.00
Average Daily Volume: 23,242
Days Low: $4.80
Year Low: $3.52
Year High: $8.19

Aldeyra Therapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Brady Todd CPresident and CEO948,8354,744,175shares bought: 918,691 / shares sold: 0 STRONG BUYApr 14 20212 months ago
Bronstein BenDirector18,64493,220shares bought: 6,144 / shares sold: 0 STRONG BUYJun 10 202111 days ago
JOYCE MARTIN JOSEPHDirector19,64498,220shares bought: 6,144 / shares sold: 0 STRONG BUYJun 10 202111 days ago
Machatha StephenChief Development Officer00Apr 14 20212 months ago
PHILLIPS GARY MDirector00Jun 10 202111 days ago
Reed JoshuaChief Financial Officer285,7741,428,870shares bought: 282,837 / shares sold: 0 STRONG BUYApr 14 20212 months ago

View all Aldeyra Therapeutics, Inc. insiders.

Aldeyra Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 10 2021ALDXAldeyra Therapeuti ...Phillips Gary M.DirectorOption ExerciseA12.9787511,349875
Jun 10 2021ALDXAldeyra Therapeuti ...Phillips Gary M.DirectorOption ExerciseA12.971,16715,1361,167
Jun 10 2021ALDXAldeyra Therapeuti ...Phillips Gary M.DirectorOption ExerciseA12.9713,534175,53613,534
Jun 10 2021ALDXAldeyra Therapeuti ...JOYCE MARTIN JOSEPHDirectorOption ExerciseA12.971,75022,6981,750
Jun 10 2021ALDXAldeyra Therapeuti ...JOYCE MARTIN JOSEPHDirectorOption ExerciseA12.974085,292408
Jun 10 2021ALDXAldeyra Therapeuti ...JOYCE MARTIN JOSEPHDirectorOption ExerciseA12.9713,534175,53613,534
Jun 10 2021ALDXAldeyra Therapeuti ...Bronstein BenDirectorOption ExerciseA12.9793312,101933
Jun 10 2021ALDXAldeyra Therapeuti ...Bronstein BenDirectorOption ExerciseA12.9787511,349875
Jun 10 2021ALDXAldeyra Therapeuti ...Bronstein BenDirectorOption ExerciseA12.9713,534175,53613,534
Apr 14 2021ALDXAldeyra Therapeuti ...Reed JoshuaChief Financial Off ...Option ExerciseA11.71150,1851,758,666150,185
Apr 14 2021ALDXAldeyra Therapeuti ...Machatha StephenChief Development O ...Option ExerciseA11.71116,2011,360,714116,201
Apr 14 2021ALDXAldeyra Therapeuti ...Brady Todd CPresident and CEOOption ExerciseA11.71250,0002,927,500250,000
Apr 14 2021ALDXAldeyra Therapeuti ...Brady Todd CPresident and CEOGrantA0.0046,6190948,835902.2 K to 948.8 K (+5.17 %)
Jan 21 2021ALDXAldeyra Therapeuti ...PERCEPTIVE ADVISORS LLC10% OwnerBuyP9.501,368,42113,000,0008,703,8797.3 M to 8.7 M (+18.65 %)
Jan 11 2021ALDXAldeyra Therapeuti ...PERCEPTIVE ADVISORS LLC10% OwnerBuyP7.6050,000380,0007,335,4587.3 M to 7.3 M (+0.69 %)

View all Aldeyra Therapeutics, Inc. insider transactions.